EC Number   |
Title |
Organism |
|---|
   3.1.4.37 | 2',3'-cGMP exists in vivo and comprises a 2',3'-cGMP-guanosine pathway |
Mus musculus |
| 3.1.4.37 | 2',3'-Cyclic nucleotide 3'-phosphodiesterase as a messenger of protection of the mitochondrial function during melatonin treatment in aging |
Rattus norvegicus |
| 3.1.4.37 | Determinants of ligand binding and catalytic activity in the myelin enzyme 2,3-cyclic nucleotide 3-phosphodiesterase |
Mus musculus |
| 3.1.4.37 | Mitochondrial 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNP) interacts with mPTP modulators and functional complexes (I-V) coupled with release of apoptotic factors |
Rattus norvegicus |
| 3.1.4.37 | Possible involvement of 2',3'-cyclic nucleotide-3'-phosphodiesterase in the protein phosphorylation-mediated regulation of the permeability transition pore |
Rattus norvegicus |
| 3.1.4.37 | Renal 2',3'-cyclic nucleotide 3'-phosphodiesterase is an important determinant of AKI severity after ischemia-reperfusion |
Mus musculus |
| 3.1.4.37 | Schwann cells metabolize extracellular 2',3'-cAMP to 2'-AMP |
Rattus norvegicus |
| 3.1.4.37 | Structural and functional evolution of 2',3'-cyclic nucleotide 3'-phosphodiesterase |
Rattus norvegicus |
| 3.1.4.37 | Structural and functional evolution of 2',3'-cyclic nucleotide 3'-phosphodiesterase |
Mus musculus |
| 3.1.4.37 | 2', 3'-cyclic nucleotide 3'-phosphodiesterase is expressed in dissociated rat cerebellar cells and included in the postsynaptic density fraction |
Rattus norvegicus |
